Assessment of the Effect of Food on ABT-143 Bioavailability

Completed · Phase 1

Conditions studied: Pharmacokinetic Variables

In brief

Single-dose, open-label, two-period crossover study of ABT-143

Key facts

Study ID

NCT00719693

Run by

AstraZeneca

People needed

115

Starts

2008-07-01

Last updated by the study team

2012-09-28

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18-55 years of age (inclusive)
• BMI 19 to 29 inclusive

You may not qualify if…

• Asian ancestry
• Concurrent participation in another study
• Females pregnant or breastfeeding

Where it is running

• Site Reference ID/Investigator# 9242 — Evansville, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.